Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTER DM HEALTHCARE 2022-23 Annual Report Analysis
Thu, 10 Aug

ASTER DM HEALTHCARE has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

ASTER DM HEALTHCARE Income Statement Analysis

  • Operating income during the year rose 16.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 6.1% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 13.6% in FY23 as against 15.0% in FY22.
  • Depreciation charges increased by 21.8% and finance costs increased by 27.0% YoY, respectively.
  • Other income grew by 54.5% YoY.
  • Net profit for the year declined by 20.9% YoY.
  • Net profit margins during the year declined from 5.9% in FY22 to 4.0% in FY23.

ASTER DM HEALTHCARE Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 102,533 119,329 16.4%
Other income Rs m 507 783 54.5%
Total Revenues Rs m 103,039 120,111 16.6%
Gross profit Rs m 15,336 16,269 6.1%
Depreciation Rs m 6,406 7,804 21.8%
Interest Rs m 3,069 3,897 27.0%
Profit before tax Rs m 6,369 5,351 -16.0%
Tax Rs m 358 596 66.5%
Profit after tax Rs m 6,011 4,755 -20.9%
Gross profit margin % 15.0 13.6
Effective tax rate % 5.6 11.1
Net profit margin % 5.9 4.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

ASTER DM HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY23 stood at Rs 47 billion as compared to Rs 36 billion in FY22, thereby witnessing an increase of 30.8%.
  • Long-term debt down at Rs 13 billion as compared to Rs 15 billion during FY22, a fall of 10.5%.
  • Current assets rose 20% and stood at Rs 49 billion, while fixed assets rose 18% and stood at Rs 99 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 148 billion as against Rs 125 billion during FY22, thereby witnessing a growth of 18%.

ASTER DM HEALTHCARE Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 39,534 44,481 12.5
 
Current Liabilities Rs m 35,586 46,553 30.8
Long-term Debt Rs m 14,664 13,123 -10.5
Total Liabilities Rs m 125,212 148,356 18.5
 
Current assets Rs m 40,965 49,216 20.1
Fixed Assets Rs m 84,248 99,141 17.7
Total Assets Rs m 125,212 148,356 18.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



ASTER DM HEALTHCARE Cash Flow Statement Analysis

  • ASTER DM HEALTHCARE's cash flow from operating activities (CFO) during FY23 stood at Rs 18 billion, an improvement of 39.6% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs -10 billion, an improvement of 70.4% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs -8 billion on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs 657 million from the Rs 648 million net cash flows seen during FY22.

ASTER DM HEALTHCARE Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m 13,140 18,340 39.6%
Cash Flow from Investing Activities Rs m -5,705 -9,719 -
Cash Flow from Financing Activities Rs m -6,860 -8,174 -
Net Cash Flow Rs m 648 657 1.5%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for ASTER DM HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 9.5, an decline from the EPS of Rs 12.0 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 309.1, stands at 32.5 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.5 times, while the price to sales ratio stands at 1.3 times.
  • The company's price to cash flow (P/CF) ratio stood at 8.7 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 205.3 238.9
TTM Earnings per share Rs 12.0 9.5
Diluted earnings per share Rs 12.0 9.5
Price to Cash Flow x 7.9 8.7
TTM P/E ratio x 16.4 32.5
Price / Book Value ratio x 2.3 2.5
Market Cap Rs m 92,372 109,418
Dividends per share (Unadj.) Rs 0.0 0.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for ASTER DM HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.1x during FY23, from 1.2x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 2.4x during FY23, from 3.1x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 10.7% during FY23, from 15.2% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 16.1% during FY23, from 17.4% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 5.8% during FY23, from 7.3% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 1.2 1.1
Debtors’ Days Days 7 7
Interest coverage x 3.1 2.4
Debt to equity ratio x 0.4 0.3
Return on assets % 7.3 5.8
Return on equity % 15.2 10.7
Return on capital employed % 17.4 16.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how ASTER DM HEALTHCARE has performed over the last 5 years, please visit here.

ASTER DM HEALTHCARE Share Price Performance

Over the last one year, ASTER DM HEALTHCARE share price has moved up from Rs 223.1 to Rs 309.1, registering a gain of Rs 86.0 or around 38.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 28,485.8 (up 0.5%). Over the last one year it has moved up from 23,223.2 to 28,485.8, a gain of 5,263 points (up 22.7%).

Overall, the S&P BSE SENSEX is up 12.1% over the year.

(To know more, check out historical annual results for ASTER DM HEALTHCARE and quarterly results for ASTER DM HEALTHCARE)

Annual Report FAQs

What is the current share price of ASTER DM HEALTHCARE?

ASTER DM HEALTHCARE currently trades at Rs 359.0 per share. You can check out the latest share price performance of ASTER DM HEALTHCARE here...

What was the revenue of ASTER DM HEALTHCARE in FY23? How does it compare to earlier years?

The revenues of ASTER DM HEALTHCARE stood at Rs 120,111 m in FY23, which was up 16.6% compared to Rs 103,039 m reported in FY22.

ASTER DM HEALTHCARE's revenue has grown from Rs 79,973 m in FY19 to Rs 120,111 m in FY23.

Over the past 5 years, the revenue of ASTER DM HEALTHCARE has grown at a CAGR of 10.7%.

What was the net profit of ASTER DM HEALTHCARE in FY23? How does it compare to earlier years?

The net profit of ASTER DM HEALTHCARE stood at Rs 4,755 m in FY23, which was down -20.9% compared to Rs 6,011 m reported in FY22.

This compares to a net profit of Rs 1,743 m in FY21 and a net profit of Rs 3,149 m in FY20.

Over the past 5 years, ASTER DM HEALTHCARE net profit has grown at a CAGR of 6.6%.

What does the cash flow statement of ASTER DM HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of ASTER DM HEALTHCARE reveals:

  • Cash flow from operations increased in FY23 and stood at Rs 18,340 m as compared to Rs 13,140 m in FY22.
  • Cash flow from investments decreased in FY23 and stood at Rs -9,719 m as compared to Rs -5,705 m in FY22.
  • Cash flow from financial activity decreased in FY23 and stood at Rs -8,174 m as compared to Rs -6,860 m in FY22.

Here's the cash flow statement of ASTER DM HEALTHCARE for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations6,00912,23315,69113,14018,340
From Investments-7,089-6,673-3,303-5,705-9,719
From Financial Activity1,344-6,748-11,161-6,860-8,174
Net Cashflow329-1,0991,199648657

What does the Key Ratio analysis of ASTER DM HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of ASTER DM HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and stood at 13.6% in FY23 as against 15.0% in FY22.
  • Net profit margins declined from 5.9% in FY22 to 4.0% in FY23.
  • Debt to Equity ratio for FY23 stood at 0.3 as compared to 0.4 in FY22.

Here's the ratio/financial analysis of ASTER DM HEALTHCARE for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)11.114.712.815.013.6
Net Profit Margin (%)4.63.62.05.94.0
Debt to Equity Ratio (x)0.60.60.50.40.3

Equitymaster requests your view! Post a comment on "ASTER DM HEALTHCARE 2022-23 Annual Report Analysis". Click here!